K M Augestad1, P M Bakaki2, J Rose3, B P Crawshaw4, R O Lindsetmo5, L M Dørum6, S M Koroukian2, C P Delaney4. 1. Department of Colorectal Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, USA; Department of Surgery, Hammerfest Hospital, Hammerfest, Norway; Norwegian National Centre of Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. Electronic address: knut.magne.augestad@telemed.no. 2. Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, USA; Population Health and Outcomes Research Core, Clinical and Translational Science Collaborative, Cleveland, Ohio, USA. 3. Case Western Reserve University, Department of Family Medicine and Community Health, Cleveland, Ohio, USA; Case Comprehensive Cancer Center, Cleveland, Ohio, USA. 4. Department of Colorectal Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, USA. 5. Department of Gastrointestinal Surgery, University Hospital North Norway, Tromsø, Norway. 6. The Norwegian Cancer Registry, Oslo, Norway.
Abstract
OBJECTIVE: The most common sites of colorectal cancer (CRC) recurrence are the local tissues, liver or lungs. The objective was to identify risk factors associated with the primary CRC tumor and cancer recurrence in these anatomical sites. METHODS: Retrospective, longitudinal analyses of data on CRC survivors. Multivariable Cox regression analysis was performed to examine the association between possible cofounders with recurrence to various anatomical sites. RESULTS: Data for 10,398CRC survivors (tumor location right colon=3870, left colon=2898, high rectum=2569, low rectum=1061) were analyzed; follow up time was up to five years. Mean age at curative surgery was 71.5 (SD 11.8) years, 20.2% received radio-chemotherapy, stage T3 (64.4%) and N0 (65.1%) were most common. Overall 1632 (15.7%) had cancer recurrence (Isolated liver n=412, 3,8%; isolated lung n=252, 2,4%; isolated local n=223, 2.1%). Risk factors associated with recurrent CRC were identified, i.e. isolated liver metastases (male: Adjusted Hazard Ratio (AHR) 1,45; colon left: AHR 1,63; N2 disease: AHR 3,35; T2 disease: AHR 2,82), isolated lung metastases (colon left: AHR 1,53; rectum high: AHR 2,48; rectum low: AHR 2,65; N2 disease 3,76), and local recurrence (glands examined<12: AHR 1,51; CRM <3mm: AHR 1,60; rectum high: AHR 2,15; N2 disease: AHR 2,58) (all p values <0001). CONCLUSION: Our study finds that the site of the primary CRC tumor is associated with location of subsequent metastasis. Left sided colon cancers have increased risk of metastatic spread to the liver, whereas rectal cancers have increased risk of local recurrence and metastatic spread to the lungs. These results, in combination with other risk factors for CRC recurrence, should be taken into consideration when designing risk adapted post-treatment CRC surveillance programs.
OBJECTIVE: The most common sites of colorectal cancer (CRC) recurrence are the local tissues, liver or lungs. The objective was to identify risk factors associated with the primary CRC tumor and cancer recurrence in these anatomical sites. METHODS: Retrospective, longitudinal analyses of data on CRC survivors. Multivariable Cox regression analysis was performed to examine the association between possible cofounders with recurrence to various anatomical sites. RESULTS: Data for 10,398CRC survivors (tumor location right colon=3870, left colon=2898, high rectum=2569, low rectum=1061) were analyzed; follow up time was up to five years. Mean age at curative surgery was 71.5 (SD 11.8) years, 20.2% received radio-chemotherapy, stage T3 (64.4%) and N0 (65.1%) were most common. Overall 1632 (15.7%) had cancer recurrence (Isolated liver n=412, 3,8%; isolated lung n=252, 2,4%; isolated local n=223, 2.1%). Risk factors associated with recurrent CRC were identified, i.e. isolated liver metastases (male: Adjusted Hazard Ratio (AHR) 1,45; colon left: AHR 1,63; N2 disease: AHR 3,35; T2 disease: AHR 2,82), isolated lung metastases (colon left: AHR 1,53; rectum high: AHR 2,48; rectum low: AHR 2,65; N2 disease 3,76), and local recurrence (glands examined<12: AHR 1,51; CRM <3mm: AHR 1,60; rectum high: AHR 2,15; N2 disease: AHR 2,58) (all p values <0001). CONCLUSION: Our study finds that the site of the primary CRC tumor is associated with location of subsequent metastasis. Left sided colon cancers have increased risk of metastatic spread to the liver, whereas rectal cancers have increased risk of local recurrence and metastatic spread to the lungs. These results, in combination with other risk factors for CRC recurrence, should be taken into consideration when designing risk adapted post-treatment CRC surveillance programs.
Authors: Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu Journal: Adv Mater Date: 2019-06-06 Impact factor: 30.849
Authors: Garrett L Jensen; Chad Tang; Kenneth R Hess; Zhongxing Liao; Daniel R Gomez Journal: Clin Exp Metastasis Date: 2017-07-25 Impact factor: 5.150
Authors: Jonah Popp; David S Weinberg; Eva Enns; John A Nyman; J Robert Beck; Karen M Kuntz Journal: Value Health Date: 2021-10-13 Impact factor: 5.101
Authors: Garrett Jensen; Chad Tang; Kenneth R Hess; Andrew J Bishop; Hubert Y Pan; Jing Li; James N Yang; Nizar M Tannir; Behrang Amini; Claudio Tatsui; Laurence Rhines; Paul D Brown; Amol J Ghia Journal: J Radiosurg SBRT Date: 2017
Authors: Janeth I Sanchez; Veena Shankaran; Joseph M Unger; Margaret M Madeleine; Noah Espinoza; Beti Thompson Journal: J Cancer Surviv Date: 2021-05-24 Impact factor: 4.442